Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Intrarenal administration of recombinant human soluble thrombomodulin ameliorates ischaemic acute renal failure.

Intrarenal administration of recombinant human soluble thrombomodulin ameliorates ischaemic acute renal failure. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Intrarenal administration of recombinant human soluble thrombomodulin ameliorates ischaemic acute renal failure. Abstract Text:

    takenori ozakiTakenori Ozaki,chabouk anasChabouk Anas,shoichi maruyamaShoichi Maruyama,tokunori yamamotoTokunori Yamamoto,kaoru yasudaKaoru Yasuda,yoshiki moritaYoshiki Morita,yasuhiko itoYasuhiko Ito,momokazu gotohMomokazu Gotoh,yukio yuzawaYukio Yuzawa,seiichi matsuoSeiichi Matsuo,

    BACKGROUND: Thrombomodulin (TM) is an endothelial anti-coagulant cofactor which also has anti-inflammatory properties. The present study was performed to investigate the effects of recombinant human soluble TM (RHS-TM) on ischaemia/reperfusion (I/R) renal injury. METHODS: A right nephrectomy was performed in rats, and the left kidney was filled with RHS-TM (0.25 mg/kg), argatroban (20 mg/kg) or a vehicle for 45 min. Before reperfusion, the fluid trapped in the kidney was completely removed. At 24 h after I/R, renal cortical blood flow was measured using a CCD video camera, and the kidneys were harvested for the study. Next, cultured human umbilical vein endothelial cells were treated with RHS-TM (2, 10 or 50 mg/ml) or a vehicle, and incubated for 5 h in culture medium containing 300 muM hydrogen peroxide. Apoptotic cell death was analysed by terminal deoxynucleotidyl transferase dUTP nick-end labelling (TUNEL) assay. RESULTS: Immunohistochemistry revealed that the level of TM expression decreased in rat kidneys after I/R. RHS-TM significantly decreased blood urea nitrogen and serum creatinine levels. It also prevented a reduction in cortical blood flow, and attenuated tubular damage and macrophage/neutrophil infiltration. In addition, the number of TUNEL-positive cells decreased significantly in rats treated with RHS-TM. In contrast, argatroban, an inhibitor of thrombin did not show significant renoprotective actions. The results of in vitro study showed that RHS-TM significantly suppressed the number of apoptotic cells. CONCLUSION: The transient intrarenal administration of RHS-TM, but not argatroban, to the kidney attenuates I/R renal injury. The present study suggests that RHS-TM would be a useful tool in preventing transplanted kidney damage or treating acute renal failure in the clinical setting.

    Intrarenal administration of recombinant human soluble thrombomodulin ameliorates ischaemic acute renal failure. Publishing Authors By Initials

    t ozakiT Ozaki,c anasC Anas,s maruyamaS Maruyama,t yamamotoT Yamamoto,k yasudaK Yasuda,y moritaY Morita,y itoY Ito,m gotohM Gotoh,y yuzawaY Yuzawa,s matsuoS Matsuo,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Intrarenal administration of recombinant human soluble thrombomodulin ameliorates ischaemic acute renal failure. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: Nephrology, dialysis, transplantation : official p

    VOLUME: 23

    Page Numbers: 110-9

    Journal Abbreviation: Nephrol. Dial. Transplant.

    ISSN: 0931-0509

    DAY: 5

    MONTH: 09

    YEAR: 2007

    Intrarenal administration of recombinant human soluble thrombomodulin ameliorates ischaemic acute renal failure. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 8706402

    Intrarenal administration of recombinant human soluble thrombomodulin ameliorates ischaemic acute renal failure. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Intrarenal administration of recombinant human soluble thrombomodulin ameliorates ischaemic acute renal failure. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Intrarenal administration of recombinant human soluble thrombomodulin ameliorates ischaemic acute renal failure.

    AFFILIATION: Department of Nephrology, Nagoya University Graduate School of Medicine, 65 Tsurumaicho, Showaku, Nagoya, Japan 466-8550, Japan. marus@med.nagoya-u.ac.jp.

    Country: England

    England Research PublicationEngland Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Nephrol Dial Transplant

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Intrarenal administration of recombinant human soluble thrombomodulin ameliorates ischaemic acute renal failure Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News